Your browser doesn't support javascript.
loading
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
Navab, Mohamad; Chattopadhyay, Arnab; Hough, Greg; Meriwether, David; Fogelman, Spencer I; Wagner, Alan C; Grijalva, Victor; Su, Feng; Anantharamaiah, G M; Hwang, Lin H; Faull, Kym F; Reddy, Srinivasa T; Fogelman, Alan M.
  • Navab M; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Chattopadhyay A; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Hough G; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Meriwether D; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736 Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Fogelman SI; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Wagner AC; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Grijalva V; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Su F; Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Anantharamaiah GM; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294.
  • Hwang LH; Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Faull KF; Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
  • Reddy ST; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736 Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736 Semel Institute for Neur
  • Fogelman AM; Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1736.
J Lipid Res ; 56(4): 871-87, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25646365

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lisofosfolípidos / Aterosclerosis / Dislipidemias / Mucosa Intestinal Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lisofosfolípidos / Aterosclerosis / Dislipidemias / Mucosa Intestinal Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article